The continuing evolution of mechanical ventricular assistance

Current Problems in Surgery

Volumn 34, Issue 4, 1997, Pages 317-386

  Argenziano, Michael ^a   Oz, Mehmet C ^b   Rose, Eric A ^a  

^a Columbia University College of Physicians and Surgeons ^*  (United States)

^b Department of Surgery ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AORTA BALLOON; ARTIFICIAL VENTILATION; CARDIOGENIC SHOCK; CARDIOPULMONARY BYPASS; EQUIPMENT DESIGN; EXTRACORPOREAL CIRCULATION; FORWARD HEART FAILURE; HEART ASSIST DEVICE; HEART RIGHT VENTRICLE FUNCTION; HEART TRANSPLANTATION; HUMAN; PATIENT SELECTION; REVIEW;

CARDIAC OUTPUT, LOW; CARDIOPULMONARY BYPASS; EQUIPMENT DESIGN; EXTRACORPOREAL CIRCULATION; HEART TRANSPLANTATION; HEART-ASSIST DEVICES; HUMANS; INTRA-AORTIC BALLOON PUMPING; PATIENT SELECTION; SHOCK, CARDIOGENIC; VENTILATOR WEANING; VENTRICULAR DYSFUNCTION, RIGHT;

EID: 0031113598     PISSN: 00113840     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0011-3840(97)80014-7     Document Type: Article

References (220)

1. Kännel WB. Epidemiological aspects of heart failure. Cardiol Clin 1989;7:1-11.
2. Armstrong PW, Moe GW. Medical advances in the treatment of congestive heart failure. Circulation 1994;88:2941-52.
3. Gillum RF. Epidemiology of heart failure in the United States. Am Heart J 1993;126:1042-7.
4. McKee PA, Castelli WP, McNamara PM, Kännel WB. The natural history of congestive heart failure: the Framingham study. N Engl J Med 1971;285:1441-6.
5. Massie BM, Conway M. Survival of patients with congestive heart failure: past, present, and future prospects. Circulation 1987;75:(suppl)IVll-IV19.
6. Hands ME, Rutherford JD, Muller JE, Davies G, Stone PH, Parker C, et al. The in-hospital development of cardiogenic shock after myocardial infarction: incidence, predictors of occurrence, outcome and prognostic factors: The MILIS Study Group. J Am Coll Cardiol 1989; 14:40-6.
7. Goldberg RJ, Gore JM, Alpert JS, Osganian V, de Groot J, Bade J, et al. Cardiogenic shock after acute myocardial infarction: incidence and mortality from a community-wide perspective, 1975 to 1988. N Engl J Med 1991 ;325:1117-22.
8. Rodeheffer RJ, Jacobsen SJ, Gersh BJ, Kottke TE. The incidence and prevalence of congestive heart failure in Rochester, Minnesota. Mayo Clin Proc 1993:68:1143-7.
9. Ho KKL, Anderson KM, Kammel WB, Grossman W, Levy D. Survival after onset of congestive heart failure in Framingham Heart Study subjects. Circulation 1993;88:107-11.
10. Edwards BS, Rodeheffer RJ. Prognostic features in patients with congestive heart failure and selection criteria for cardiac transplantation. Mayo Clin Proc 1992;67: 485-92.
11. Gradman A, Deedwania P, Cody R, Massie B, Packer M, Pitt B, et al. (for the Captopril-Digoxin Study Group). Predictors of total mortality and sudden death in mild to moderate heart failure. J Am Coll Cardiol 1985;55:1037-42.
12. Mancini DM, Eisen H, Kussmaul W, Mull R, Edmunds LH, Wilson JR. Value of peak exercise oxygen consumption for optimal timing of cardiac transplantation in ambulatory patients with heart failure. Circulation 1991;83:778-86.
13. Lee WH, Packer M. Prognostic importance of serum sodium concentration and its modification by converting enzyme inhibition in patients with severe chronic heart failure. Circulation 1986;75:257-62.
14. Annual Report of the US Scientific Registry for Organ Transplantation and the Organ Procurement and Transplantation Network: Transplant Data: 1988-1991. Richmond, VA: UNOS, 1993:ES-20.
15. 1993 Annual Report of the US Scientific Registry for Transplant Recipients and the Organ Procurement and Transplantation Network. UNOS, Richmond, VA, and the Division of Organ Transplantation, Bureau of Health Resources Development, Health Resources and Services Administration, US Department of Health and Human Services, Bethesda, MD.
16. Stevenson LW, Fowler MB, Schröder JS, Stevenson WG, Dracup KA, Fond V. Poor survival of patients with idiopathic dilated cardiomyopathy considered too well for transplantation. Am J Med 1987;83:871-6.
17. Frazier OH, Macris MP, Radovancevic B, editors. Support and replacement of the failing heart. Philadelphia: Lippincott-Raven Publishers, 1996.
18. Shumakov VI. Iskusstvennoje serdee. Moscow: Izd Znanie, 1975.
19. Gibbon JH. The application of a mechanical heart and lung apparatus to cardiac surgery. Minn Med 1954;37:171-3.
20. Moulopoulos SD, Topaz SR, Kolff WJ. Extracorporeal assistance to the circulation and intraaortic balloon pumping. Trans Am Soc Artif Intern Organs 1962;8:86.
21. Kantrowitz A, Tjonneland S, Freed PS, Phillips SJ, Butner AN, Sherman JL Jr, et al. Initial clinical experience with intraaortic balloon pumping in cardiogenic shock. JAMA 1968;203:113-8.
22. Holman WL, Bourge RC, McGiffin DC, Kirklin JK. Ventricular assist: experience with a pulsatile heterotopic device. Semin Thorac Cardiovasc Surg I994;6:147-53.
23. Development of mechanical circulatory support systems, in artificial heart and assist devices: directions, needs, costs, societal and ethical issues. U.S. Department of Health and Human Services, National Institutes of Health, 1985.
24. DeBakey ME. Left ventricular bypass pump for cardiac assistance. Am J Cardiol 1971;27:3-11.
25. Hogness JR, Van Antwerp M, eds. The artificial heart: protoypes, policies, and patients. Committee to Evaluate the Artificial Heart Program of the National Heart. Lung, and Blood Institute, Washington, DC: National Academy Press, 1991:74.
26. Norman JC, Cooley DA, Igo SR. Prognostic indices for survival during postcardiotomy intra-aortic balloon pumping. J Thorac Cardiovasc Surg 1977:74: 709-14.
27. Votapka TV, Pennington DO. Circulatory assist devices in congestive heart failure. Cardiol Clin 1994:12:143-54.
28. Page DL, Caulfield JB, Kastor JA, De Sanctis RW, Sanders ÇA, et al. Myocardial changes associated with cardiogenic shock. N Engl J Med 1971:285:133-7.
29. Allen BS, Rosenkranz E, Buckberg GD, Dartyan H, Laks H, Tillisch J, et al. Studies on prolonged acute regional ischemia. VI. Myocardial infarction with left ventciular power failure: a medical surgical emergency requiring urgent revascularization with maximal protection of remote muscle. J Thorac Cardiovasc Surg 1989:98:691-703.
30. Lee L, Bates ER, Pitt B, Walton JA, Laufer N, O'Neill WW, et al. Percutaneous transluminal angioplasty improves survival in acute myocardial infarction complicated by cardiogenic shock. Circulation 1988:78:1345-51.
31. Burton NA, Lefrak EA, Macmanus Q, Hill A, Marino JA, Speir AM, et al. A reliable bridge to cardiac transplantation: the TCI left ventricular assist device. Ann Thorac Surg 1993:55:1425-31.
32. Burnett CM, Duncan JM, Frazier OH, Sweeney MS, Vega JD, Radovancevic B. Improved multiorgan function after prolonged univentricular support. Ann Thorac Surg 1993:55:65-71.
33. Jaski BEW, Branch KR, Adamson R, Peterson KL, Gordon JB, Hoagland PM, et al. Exercise hemodynamics during long-term implantation of a left ventricular assist device in patients awaiting heart transplantation. J Am Coll Cardiol 1993:22:1574-80.
34. Kormos RL, Murali S, Dew MA, Armitage JM, Hardesty RL, Borovetz HS, et al. Chronic mechanical circulatory support: rehabilitation, low morbidity, and superior survival. Ann Thorac Surg 1994:57:51-8.
35. Frazier OH, Macris MP, Myers TJ, Duncan JM, Radovancevic B, Purnis SM, et al. Improved survival after extended bridge to cardiac transplantation. Ann Thorac Surg 1994:57:1416-22.
36. Baldwin RT, Duncan JM, Radovancevic B, Frazier OH, Abou-Awdi NL. Recovery of pulmonary function in patients undergoing extended left ventricular assistance. Chest 1992:102:45-9.
37. Dasse KA, Frazier OH, Lesnik JM, Myers T, Burnett CM, Poirer VL. Clinical response to ventricular assistance versus transplantation in a series of bridge to transplant patients. ASAIO J 1992;38:M622-M626.
38. Reedy JE, Pennington DG, Miller LW, McBride LR, Lohmann DP, Noedel NR, et al. Status I heart transplant patients: conventional versus ventricular assist device support. J Heart Lung Transplant 1992:11:246-51.
39. Frazier OH, Rose EA, McCarthy P, Burton NA, Tector A, Levin H, et al. Improved mortality and rehabilitation of transplant candidates treated with a long-term implantable left ventricular assist system. Ann Surg 1995;222:327-38.
40. Birovljev S, Radovancevic B, Burnett CM, Vega JD, Bennink G, Lonquist JL, et al. Heart transplantation after mechanical circulatory support: four year's experience. J Heart Lung Transplant 1992:11:240-6.
41. Farrar DJ, Hill JD. Univentricular and biventricular Thoratec VAD support as a bridge to transplantation. Ann Thorac Surg 1993;55:276-82.
42. Frazier OH, Rosé EA, Macmanus Q, Burton NA, Lefrak EA, Poirier VL, et al. Multicenter evaluation of the HeartMate 1000 IP left ventricular assist device. Ann Thorac Surg 1992;53:1080-8.
43. Alcan KE, Stertzer SH, Wallsh E, Bruno MS, DePasquale NP. Current status of intra-aortic balloon counterpulsation in critical care cardiology. Crit Care Med 1984;12;489-95.
44. Kantrowitz A, Krakauer JS, Rosenbaum A, ButnerAN, Freed PS, Jaron D. Phase-shift balloon pumping in medically refractory cardiogenic shock. Am J Cardiol 1969;99:739-43.
45. Krakauer JS, Rosenbaum A, Freed PS, Jaron D, Kantrowitz A. Clinical management ancillary to phase-shift balloon pumping in cardiogenic shock. Am J Cardiol 1971;27:123-8.
46. Scheldt S, Wilner G, Mueller H, Summers D, Lesch M, Wolff G, et al. Intraaortic balloon counterpulsation in cardiogenic shock: report of a cooperative clinical trial. N Engl J Med 1973;288:979-84.
47. Buckley MJ, Graver JM, Gold HK, Mundth ED, Daggett WM, Austen WG. Intra-aortic balloon pump assist for cardiogenic shock after cardiopulmonary bypass. Circulation 1972;46(suppl):II-76.
48. Kaiser GC, Marco JD, Barner HB, Codd JE, Laks H, Willman VL. Intra-aortic balloon assistance. Ann Thorac Surg 1976;21:487-91.
49. Feola M, Wiener L, Walinsky P, Kasparian H, Duca P, Gottlieb R, et al. Improved survival after coronary bypass surgery in patients with poor left ventricular function: role of intraaortic balloon counterpulsation. Am J Cardiol 1977:39:1021-6.
50. Beckman CB, Geha AS, Hammond GL, Baue AE. Results and complications of intraaortic balloon counterpulsation. Ann Thorac Surg 1977;24:550-9.
51. McEnany MT, Kay H, Buckley MJ. Clinical experience with intraaortic balloon pump support in 728 patients. Circulation 1978;58(suppl):I-124.
52. Pennington DG, Swartz MT, Codd JE, Merjavy JP, Kaiser GC. Intraaortic balloon pumping in cardiac surgical patients: a nine-year experience. Ann Thorac Surg 1983:36:125-31.
53. Fuchs RM, Brin KP, Brinker JA, Guzman PA, Heuser RR, Yin FCP. Augmentation of regional coronary blood flow by intra-aortic balloon counterpulsation in patients with unstable angina. Circulation 1983:68:117-23.
54. MacDonald RG, Hill JA, Feldman RL. Failure of intraaortic balloon counterpulsation to augment distal coronary perfusion pressure during percutaneous transluminal coronary angioplasty. Am J Cardiol 1987:59:359-61.
55. Alderman JD, Gabliani GI, McCabe CH, Brewer CC, Loreu BH, Pasternak RC, et al. Incidence and management of limb ischemia with percutaneous wire-guided intraaortic balloon catheters. J Am Coll Cardiol 1987:9:524-30.
56. Creswell LL, Rosenbloom M, Cox JL, Ferguson TB Sr, Kouchoukos NT, Spray TL, et al. Intraaortic balloon counterpulsation: patterns of usage and outcome in cardiac surgery patients. Ann Thorac Surg 1992:54:11-20.
57. Alien BS, Okamoto F, Buckberg GD, Bugyi H, Lear J. Reperfusion conditions: critical importance of total ventricular decompression during regional reperfusion. J Thorac Cardiovasc Surg 1986:92:605-8.
58. Wampler RK, Moise JC, Frazier OH, Olsen DB. In vivo evaluation of a peripheral vascular-access axial flow blood pump. ASAIO Trans 1988:34:450-4.
59. Rutan PM, Rountree WD, Myers KK, Baker LE. Initial experience with the Hemopump. Crit Care Nurs North Am 1989:1:527-34.
60. Frazier OH, Wampler RK, Duncan JM, Dear WE, Macris MP, Parnis SM, et al. First human use of the Hemopump, a catheter-mounted ventricular assist device. Ann Thorac Surg 1990;49:299-304.
61. Buler KC, Moise JC, Wampler RK. The Hemopump: a new cardiac prosthesis device. IEEE Trans Biomed Eng 1990;37:193-6.
62. Wampler RK, Frazier OH, Lansing AM, Smalling RW, Nicklas JM, Phillips SJ, et al. Treatment of cardiogenic shock with the Hemopump left ventricular assist device. Ann Thorac Surg 1991;52:506-13.
63. Lonn U, Peterzen B, Granfeldt H, Babic A, Casimir-Ahn H. Hemopump treatment in patients with postcardiotomy heart failure. Ann Thorac Surg 1995:60:1067-71.
64. Wampler RK, Aboul-Hosn W, Cleary M, Saunders M. The sternotomy Hemopump: a second generation intraarterial ventricular assist device. ASAIO J 1993;39: M218-M223.
65. Wiebalck AC, Wouters PF, Waldenberger FR, Akpinar B, Lauwers PM, Demeyere RH, et al. Left ventricular assist with an axial flow pump (Hemopump): clinical application. Ann Thorac Surg 1993;55:1141-6.
66. Meyns BP, Sergeant PT, Daenen WJ, Flameng WJ. Left ventricular assistance with the transthoracic 24F hemopump for recovery of the failing heart. Ann Thorac Surg 1995:60:392-7.
67. Frazier OH, Macris MR, Wampler RK, Duncan JM, Sweeney MS, Fuqua JM. Treatment of cardiac allograft failure by use of an intraaortic axial flow pump. J Heart Transplant 1990;9:408-14.
68. Casmir-Ahn H, Lonn U, Peterzen B. Clinical use of the hemopump cardiac assist system for circulatory support. Ann Thorac Surg 1995;59:S39-S45.
69. Lynch MF, Paterson D, Baker V. Centrifugal blood pumpiong for open heart surgery. Minn Med 1978;61:536-8.
70. Curtis JJ. Centrigugal mechanical assist for postcardiomy ventricular failure. Semin Thorac Cardiovasc Surg 1994;6:140-6.
71. Golding LAR, Steward RW, Loop FD. Centrifugal pumps in clinical practice. In: Unger F, editor. Assisted circulation. Berlin: Springer-Verlag, 1989:160-6.
72. Pennington DG, Merjavy JP, Swartz MT, Willman VL. Clinical experience with a centrifugal pump ventricular assist device. ASAIO Trans 1982;28:93-9.
73. Hoerr HR, Kraemer MF, Williams JL. In-vitro comparison of the blood handling by the constrained vortex and twin roller blood pumps. J Extra Corpor Technol 1987;19:316-21.
74. Iatridis E, Chan T. An evaluation of vortex, centrifugal and roller pump systems. Proceedings: International workshop on rotary blood pumps, Vienna, Austria, September 1991.
75. Jakob H, Kutschera Y, Palzer B, Pnellwitz W, Oelert H. In-vitro assessment of centrifugal pumps for ventricular assist. Artif Organs 1990:14:278-83.
76. Rowles JR, Mortimer BJ, Olsen DB. Ventricular assist and total artificial heart devices for clinical use in 1993. ASAIO J 1993:39:840-55.
77. Killen DA, Piehler JM, Borkon AM, Reed WA. Bio-Medicus ventricular assist device for salvage of cardiac surgical patients. Ann Thorac Surg 1991;52:230-5.
78. Minami K, Posival H, El-Bynayosy A, Korner MM, Schrofel H, Murray E, et al. Mechanical ventricular support using pulsatile Abiomed BVS 5000 and centrifugal Biomedicus-pump in postcardiotomy shock. Int J Artif Organs 1994:17:492-8.
79. Bolman RM, Cox JL, Marshall W, Kouchoukos N, Spray TL, Cance C, et al. Circulatory support with a centrifugal pump as a bridge to cardiac transplantation. Ann Thorac Surg 1989;47:108-12.
80. Golding LAR, Stewart RW, Sinkewich M, Smith W, Cosgrove D. Nonpulsatile ventricular assist bridging to transplantation. ASAIO Trans 1988;34:476-9.
81. Bianchi JJ, Swartz MT, Raithel SC, Braun PR, Illes MZ, Barnett MG, et al. Initial clinical experience with centrifugal pumps coated with the Carmeda process. ASAIO Trans 1992;38:M 143-6.
82. Campanella C, Cameron E, Sinclair C, Feilberg VL, Hider C, Prasad S, et al. Preliminary results of left heart bypass in pigs using heparin-coated centrifugal pump. Ann Thorac Surg 1991;52:245-9.
83. Hammerschmidt DE, Stroncek DF, Bowers TK, Lammi-Keefe CJ, Kurth DM, Ozalins A, et al. Complement activation and neutropenia occuring during cardiopulmonary bypass. J Thorac Cardiovasc Surg 1981;81:370-7.
84. Kirklin JK, Westaby S, Blackstone EH, Kirklin JW, Chenoweth DE, Pacifico AD, et al. Complement and the damaging effects of cardiopulmonary bypass. J Thorac Cardiovasc Surg 1983;86:845-57.
85. Tennenberg JD, Claroy CW, Bailey WW, Solomkin JS. Complement activation and lung permeability during cardiopulmonary bypass. Ann Thorac Surg 1990;50:597-601.
86. Pennington DG, Swartz MT. Management: by circulatory assist devices. Cardiol Clin 1989;7:195-204.
87. Joyce LD, Riser JC, Bales F, King RM, Toninato CJ, Hansen J. Experience with the Sarns centrifugal pump as a ventricular assist device. ASAIO Trans 1990;36: M619-23.
88. Curtis JJ, Walls JT, Demmy TL, Boley TM, Schmaltz RA, GOSS CF, et al. Clinical experience with the Sarns Centrifugal pump. Artif Organs 1993;17:630-3.
89. McBride LR. Bridging to cardiac transplantation with external ventricular assist devices. Semin Thorac Cardiovasc Surg 1994;6:169-73.
90. Champsaur G, Ninet J, Vigneron M, Cochet P, Neidecker J, Boissonnat P. Use of the Abiomed BVS System 5000 as a bridge to cardiac transplantation. J Thorac Cardiovasc Surg 1990;100:122-8.
91. Kaan GL, Noyez L, Vincent JG, Van De Wall H, Skotnicki SH, Lacquet LK. Management of postcardiotomy cardiogenic shock with a new pulsatile ventricular assist device: initial clinical results. ASAIO Trans 1991;37:559-63.
92. Castells E, Calbet JM, Fontanillas C, Ganados J, Manito N, Miralles A, et al. Ventricular circulatory assistance with the Abiomed system as a bridge to heart transplantation. Transplant Proc 1995;27:2343-5.
93. Farrar DJ, Litwak P, Lawson JH, Ward RS, While KA, Robinson AJ, et al. In vivo evaluations of a new thromboresistant polyurethane for artifical heart blood pumps. J Thorac Cardiovasc Surg 1988;95:191-200.
94. Ganzel BL, Gray LA, Slater AD, Mavroudis C. Surgical techniques for the implantation of heterotropic prosthetic ventricules. Ann Thorac Surg 1989;47:113-30.
95. Termulen DF, Swartz MT, Pennington DG. Thromboembolic complications with the Pierce-Donachy ventricular assist device. ASAIO Trans 1989;35:616-8.
96. Pennington DG, Kanter KR, McBride LR, Kaiser GC, Barner HB, Miller LW, et al. Seven years experience with the Pierce-Donachy ventricular assist device. J Thorac Cardiovasc Surg 1988;96:901-11.
97. Farrar DJ, Hill JD, Gray LA, Pennington DG, McBride LR, Pierce WS, et al. Heterotropic prosthetic ventricles as a bridge to cardiac transplantation: a multicenter study in 29 patients. N Engl J Med 1988;318:333-40.
98. Farrar DJ, Lawson JH, Litwak P, Cederwall G. Thoratec VAD system as a bridge to heart transplantation. J Heart Transplant 1990:9:415-23.
99. Mozkowitz AJ, Weinberg AD, Oz MC, Williams DL. Quality of life with a ventricular assist device: the potential for destination therapy. J Heart Lung Transplant 1996;15:S75.
100. Portner PM, Jassawalla JS, Chen H, Conley MG, Maeder PA, Oyer PE. A new dual pusher-plate left hear assist blood pump. Artif Organs 1979;3(suppl)361-5.
101. McCarthy PM, Portner PM, Tobler HG, Starnes VA, Ramasamy N, Oyer PE. Clini-cal experience with the Novacor ventricular assist system: bridge to transplantation and the transition to permanent application. J Thorac Cardiovasc Surg 1991;102:578-87.
102. Kormos RL, Borovetz HS, Pristas JM, Laree J, Armitage JM, Stuart RS, et al. LVAS pump performance following initiation of left ventricular assistance. ASAIO Trans 1990;36:M703-5.
103. Korfer R, El-Banayosy A, Posival H, Minami K, Korner MM, Arusoglu L, et al. Mechanical circulatory support: the Bad Oeynhausen experience. Ann Thorac Surg 1995;59:S56-S63.
104. Vetter HO, Kaulbach HG, Schmilz C, Forst A, Überfuhr P, Kreuzer E, et al. Experience with the Novacor left ventricular assist system as a bridge to cardiac transplantation, including the new wearable system. J Thorac Cardiovasc Surg 1995; 109:74-80.
105. Dasse KA, Chipman SD. Sherman CN, Levine AH, Frazier OH. Clinical experience with textured blood contacting surfaces in ventricular assist devices. ASAIO Transactions 1987;10:418-25.
106. McCarthy PM, Sabik JF. Implantable circulatory support devices as a bridge to heart transplantation. Semin Thorac Cardiovasc Surg 1994:6:174-80.
107. Pennington DC, Farrar DJ, Loisance D, Pae WE, Emery RW. Patient selection. Ann Thorac Surg 1993;55:206-12.
108. Jett GK. Postcardiotomy support with ventricular assist devices: selection of recipients. Semin Thorac Cardiovasc Surg 1994;6:136-9.
109. Pae WE, Miller CA, Matthews Y, Pierce WS. Ventricular assist devices for postcardiotomy shock. J Thorac Cardiovasc Surg 1992:74:709-20.
110. Pae WE. Ventricular assist devices and total artificial hearts: a ASAIO-ISHLT registry experience. Ann Thorac Surg 1993:55:295-8.
111. Parascandola SA, Pae WE, Davis PK, Miller CA, Pierce WS, Waldhausen JA. Determinants of survival in patients with ventricular assist devices. ASAIO Trans 1988;34:222-8.
112. Pennington DG, McBride LR, Kanter KR, Swartz MT, Lagunoff D, Palmer D, et al. Effect of perioperative myocardial infarction on survival of postcardiotomy patients supported with ventricular assist devices. Circulation 1988;78 (suppl): 110-5.
113. Wareing TH, Kouchoukos NT. Postcardiotomy mechanical circulatory support in the elderly. Ann Thorac Surg 1991:51:443-7.
114. Baldwin RT, Slogoff S, Noon GP, Sekela M, Frazier OH, Edelman SK, et al. A model to predict survival at time of postcardiotomy intraaortic balloon pump insertion. Ann Thorac Surg 1993;55:908-13.
115. Moroney D, Swartz MT, Reedy JE, Lohmann DP, McBride LR, Pennington DG. The importance of ventricular arrhythmias in recovery patients with ventricular assist devices. ASAIO Trans 1991:37:516-7.
116. Pennington DG, Swartz MT. Patient selection for mechanical circulatory support. In: Ott RA, Gutfmger DE, Gazzaniga AB, editors. Cardiac surgery: state of the art reviews. Vol 7. No 2. Philadelphia: Hanley and Belfus, 1993:229-39.
117. Farrar DJ, and Thoratec Investigators. Preoperative predictors of survival in patients with Thoratec ventricular assist devices as a bridge to heart transplantation. J Heart Lung Transplant 1994;13:93-101.
118. Reedy JE, Swartz MT, Termuhlen DF, Pennington DG, McBride LR, Miller LW, et al. Bridge to heart transplantation: importance of patient selection. J Heart Transplant 1990;9:473-81.
119. Swartz MT, Votapka TV, McBride LR, Lohmann DP, Moroney DA, Pennington DG. Risk stratification in patients bridged to cardiac transplantation. Ann Thorac Surg 1994;58:1142-5.
120. Oz MC, Goldstein DJ, Pepino P, Weinberg AD, Thompson SM, Catanese Ka, et al. Screening scale predicts patients successfuly receiving long-term implantable left ventricular assist devices. Circulation 1995;92(suppl):II-169.
121. Pennington DG, McBridge LR, Swartz MT. Use of the Pierce-Donachy ventricular assist device in patients with cardiogenic shock after cardiac operations. Ann Thoarc Surg 1989;47:130-5.
122. Hill JD. Bridging to cardiac transplantation. Ann Thorac Surg 1989;47:167-71.
123. Ott R A, Mills TC, Eugene J, Gazzaniga AB. Clinical choices for circulatory assist devices. ASAIO Trans 1990;36:792-8.
124. Magovern GJ, Wampler RW, Joyce LD, Wareing TH. Nonpulsatile circulatory support: techniques of insertion. Ann Thorac Surg 1993;55:266-72.
125. Portner PM, Oyer PE, McGregor CGA. First human use of an electrically powered implantable ventricular assist system. Artif Organs 1985;9:36.
126. McCarthy PM, Wang N, Vargo R. Preperitoneal insertion of the HeartMate 1000 IP implantable left ventricular assist device. Ann Thorac Surg 1994;57:634-8.
127. Oz MC, Levin HR, Rose EA. Technique for removal of left ventricular assist devices. Ann Thorac Surg 1994;58:257-8.
128. McBride L. Bridging to cardiac transplantation with external ventricular assist devices. Semin Thorac Cardiovasc Surg 1994;6:169-73.
129. Tanaka K, Wada K, Morimoto T, Shomura S, Nasu M, Okada Y, et al. Hemostatic alterations caused by ventricular assist devices for postcardiotomy heart failure. Artif Organs 1991; 15:59-65.
130. Cryer HG, Mavroudis C, Yu J, Roberts AM, Cue JI, Richardson JD, et al. Shock, transfusion and pneumonectomy: death is due to right heart failure and increased pulmonary vascular resistance. Ann Surg 1990;212:197-201.
131. Shenkar R, Coulson WF, Abraham E. Hemorrhage and resuscitation induce alterations in cytokine expression and the development of acute lung injury. Am J Respir Cell Mol Biol 1994;10:290-7.
132. Bidstrup BP, Royston D, Sapsford RN, Taylor KM. Reduction in blood loss and blood use after cardiopulmonary bypass with high-dose aprotinin. J Thorac Cardiovasc Surg 1989;97:364-72.
133. Bidstrup BP, Harrison J, Royston D, Taylor KM, Treasure T. Aprotinin therapy in cardiac operations: a report on use in 41 cardiac centers in the United Kingdom. Ann Thorac Surg 1993;55:971-6.
134. Havel M, Teufelsbauer H, Knobl P, Dalmatiner R, Jasch P, Zwölfer W, et al. Effect of intraoperative aprotinin administration on postoperative bleeding in patients undergoing cardiopulmonary bypass operations. J Thorac Cardiovasc Surg 1991;101:968-72.
135. Dietrich W, Barankay A, Dilthey G, Henze R, Niekau E, Sebening F, et al. Reduction of homologous blood requirement in cardiac surgery by intraoperative aprotinin application: clinical experience in 152 cardiac surgical patients. Thorac Cardiovasc Surg 1989;37:92-8.
136. Lemmer JH, Stanford W, Bonney SL, Breen JF, Chomka EV, Eldredge WJ, et al. Aprotinin for coronary bypass operations: efficacy, safety and influence on early saphenous vein graft patency. J Thorac Cardiovasc Surg 1994;107:543-53.
137. Goldstein DJ, Seldomridge JA, Chen JM, Catanese KA, DeRosa CM, Weinberg AD, et al. Use of aprotinin in LVAD recipients reduces blood loss, blood use, and perioperative mortality. Ann Thorac Surg 1995;59:1063-8.
138. Seto S, Kher V, Scicli AG, Beierwaltes WH, Carretero OA. The effect of aprotinin therapy for insertion of ventricular sasist devices for staged cardiac transplantation. J Heart Lung Transplant 1994;23:S56.
139. Rustom R, Jackson MJ, Critchley M, Bone JM. Tubular metabolism of aprotinin 99m Tc and urinary ammonia: effects of proteinuria. Miner Electrolyte Metab 1992:18:108-12.
140. Pae WE, Rosenberg G, Donachy P. Mechanical circulatory assistance for postoperative shock: a three year experience. ASAIO Trans 1980;26:256-60.
141. Cave AC, Manche A, Derias NW, Hearse DJ. Thromboxane A2 mediates pulmonary hypertension after cardiopulmonary bypass in the rabbit. J Thorac Cardiovasc Surg 1993:106:959-67.
142. Semigran MJ, Cockrill BA, Kacmarek R, Thompson BT, Zapol WM, Dec GW, et al. Hemodynamic effects of inhaled nitric oxide in heart failure. J Am Coll Cardiol 1994:24:982-8.
143. Komai H, Yamamoto F, Kazuhiko T, Murashita T, Shibata T, Sakai H, et al. Increased lung injury in pulmonary hypertensive patients during open heart operations. Ann Thorac Surg 1993:55:1147-52.
144. Francis GS, Goldsmith SR, Levine TB, Olivari MT, Cohn JN. The neurohumoral axis in congestive heart failure. Ann Intern Med 1984:101:370-7.
145. Beghetti M, Habre W, Friedli B, Berner M. Continuous low dose inhaled nitric oxide for treatment of severe pulmonary hypertension after cardiac surgery in paediatric patients. Br Heart J 1995;73:65-8.
146. Wessel DL, Adatia I, Giglia TM, Thompson JE, Kulik TJ. Use of inhaled nitric oxide and acetylcholine in the evaluation of pulmonary hypertension and endothelial function after cardiopulmonary bypass. Circulation 1993:88:2128-38.
147. Celermajer DS, Cullen S, Deanfield JE. Impairment of endothelium-dependent pulmonary artery relaxation in children with congenital heart disease and abnormal pulmonary hemodynamics. Circulation 1993:87:440-6.
148. Dinh Zuan AT, Higgenbottam TW, Clelland C, Pepka-Zaba J, McGoldrick J, Wallwork J. Impairment of endothelum-dependent vasorelaxation in secondary pulmonary hypertension. Eur Respir J 1989;2:667S.
149. Komai H, Adatia IT, Elliott MJ, de Leva! MR, Haworth SG. Increased plasma levels of endothelin-1 after cardiopulmonary bypass in patients with pulmonary hypertension and congenital heart disease. J Thorac Cardiovasc Surg 1993:106:473-8.
150. Oz MC, Slater JP, Edwards N, Dickstein ML, Beck JR, Spotnitz HM, et al. Desaturated venous-to-arterial shunting reduces right-sided heart failure after cardiopulmonary bypass. J Heart Lung Transplant 1995:14:172-6.
151. Miller D, Moreno-Cabral R, Stinson E. Pulmonary artery balloon counterpulsation for acute right ventricular failure. J Thorac Cardiovasc Surg 1980:80:760-3.
152. Moran J, Oprovil M, Gorman A, Rastegar H, Meyers SN, Michaelis LL, et al. Pulmonary artery balloon counterpulsation for right ventricular failure II: clinic experience. Ann Thorac Surg 1984:38:254-9.
153. Spence P, Weisel R, Easdown J, Jabr AK, Yap V, Salerno TA, et al. The hemodynamic effects and mechanism of action of pulmonary artery balloon counterpulsation in the treatment of right ventricular failure during left heart bypass. Ann Thorac Surg 1985:39:329-35.
154. Oz MC, Argenziano M, Catanese KA, Gardocki MT, Goldstein DJ, Ashton RC, Rose EA, Levin HR. Bridge experience with long-term implantable left ventricular assist devices: are they an alternative to transplantation? Circulation 1997 (in press).
155. Pepke-Zaba J, Higenbottam TW, Dinh Xuan AT, Stone D, Wallwork J. Inhaled nitric oxide as a cause of selective pulmonary vasodilatation in pulmonary hypertension. Lancet 1991;338:1173-4.
156. Roberts JD Jr, Lang P, Bigatello Lm, Vlahakes GJ, Zapol WM. Inhaled nitric oxide in congenital heart disease. Circulation 1993:87:447-53.
157. Rossaint R, Falke KJ, Lopez F, Slama K, Pison U, Zapol WM. Inhaled nitric oxide for the adult respiratory distress syndrome. N Engl J Med 1993;328:399-405.
158. Snow DJ, Gray SJ, Ghosh S, Foubert L, Oduro A, Higenbottam TW, et al. Inhaled nitric oxide in patients with normal and increased pulmonary vascular resistance after cardiac surgery. Br J Anaesth 1994;72:185-9.
159. Girard C, Lehot JJ, Pannetier JC, Filley S, French P, Estanove S. Inhaled nitric oxide after mitral valve replacement in patients with chroni pulmonary hypertension. Anesthesiology 1992;77:880-3.
160. Rich GF, Murphy GD, Roos CM, Roger MS, Johns A. Inhaled nitric oxide selective pulmonary vasodilatation in cardiac surgical patients. Anesthesiology 1993;78: 1028-35.
161. Salamonsen RF, Kaye D, Esmorre DS. Inhalation of nitric oxide provides selective pulmonary vasodilatation, aiding mecganical cardiac assist with Thoratec left ventricular assist device. Anaesth Intensive Care 1994;22:209-10.
162. Hirsch AT, Majzoub JA, Ren CJ, Scales KA, Creager MA. Contribution of vasopressin to blood pressure during hypovolemic hypotension in humans. J Appl Physiol 1993;75:1984-8.
163. Grollman A, Geiling EMK. The cardiovascular and metabolic reactions of man ito the intramuscular injuection of posterior pituitary liquid (pituitrin), pitressin and pitocin. J Pharmacol Exp Ther 1932;46:447-60.
164. Graybiel A, Glendy RE. Circulatory effects following the intravenous administration of pitressin in normal persons and in patients with hypertension and angina pectoris. Am Heart J 1941;21:481-9.
165. Wagner HN, Braunwald E. The presser effect of the antidiuretic principle of the posterior pituitary in orthostatic hypotension. J Clin Invest 1956;35:1412-8.
166. Bisset GW, Chowdrey HS. A cholinergic link in the reflex release of vasopressin by hypotension in the rat. J Physiol (Lond) 1984;354:523-45.
167. Fauchet R, Genetet B, Gueguen M, Leguerrier A, Rioux C, Logeais Y. Transfusion therapy and HLA antibody response in patients undergoing open heart surgery. Transfusion 1982;22:320-2.
168. Burlingham WJ, Stratta R, Mason B, et al. Risk factors for sensitization by blood transfusions. Transplantation 1989;47:140-4.
169. Lavee J, Kormos RL, Duquesnoy RJ, Zerbe TR, Armitage JM, Vanek M, et al. Influence of panel-reactive antibody and lymphocytotoxic crossmatch on survival after heart transplantation. J Heart Lung Transplant 1991; 10:921-30.
170. Welsh KI, Burgos H, Batchelor JR. The immune response to allogenic rat platelet: Ag. B antigens in matrix for lacking la. Eur J Immunol 1977;7:267-72.
171. Claas FHJ, Smeenk RJT, Schmidt R, Van Steenbrugge GJ, Gernisse JG. Alloimmunization against the MHC antigens after platelet transfusions is due to contaminating leukocytes in the blatelet suspension. Exp Hematol 1981;9:84-9.
172. Elghouzzi MH, Vedrenne JB, Jullien AM, Delcey D, Nadal M, Habibi B. Etude technique immunologique et clinique des performances de filtration du sang a l'aide de l'appareil Erypur. Rev Fr Transfus Immunohematol 1981;24:579-95.
173. Eernisse JG, Brand A. Prevention of platelet refractoriness is due to HLA antibodies by administration of leukocyte-poor blood components. Exp Hematol 1981;9:7783.
174. Schiffer CA, Dutcher JP, Aisner J, Jogge D, Wiernik PH, Reilly JP. A randomized trial of leukocyte-depleted platelet transfusion to modify alloimmunization in patients with leukemia. Blood 1983;62:815-20.
175. Fisher M, Chapman JR, Ting A, Morris PJ. Alloimmunization to HLA antigens following transfusion with leukocyte-poor and purified platelet suspensions. Vox Sang 1985;49:331-5.
176. Murphy MF, Metcalfe P, Thomas H, Eve J, Ord J, Lister TA, et al. Use of leukocyte-poor blood components and HLA-matched platelet donors to prevent HLA alloimmunization. Br J Haematol 1986;62:529-34.
177. Andreu G, Dewailly J, Leberre C, Quarre MC, Bidet ML, Tardivel R, et al. Pré-vention of HLA immunization with leukocyte-poor packed red cells and platelet concentrates obtained by filtration. Blood 1988;72:964-9.
178. Aria H, Schwartz MT, Pennington DG, Moriyama Y, Miller L, Peigh P, et al. Importance of ventricular arrhythmias in bridge patients with ventricular assist devices. ASAIO Trans 1991;37:M427-8.
179. Farrar HD, Hill JD, Gray LA, Galbraith TA, Chow E, Hershon JJ. Successful biventricular circulatory support as a bridge to cardiac transplantation during prolonged ventricular fibrillation and asystole. Circulation 1989;80(suppl): III147-III151.
180. Oz MC, Rose EA, Slater JP, Kuiper JJ, Catanese KA, Levin HR. Malignant ventricular arrhythmias are not well tolerated in patients receiving long-term left ventricular assist devices. J Am Coll Cardiol 1994;24:1688-91.
181. Bourge RC, Kirklin JK, Naftel DC, White C, Mason DA, Epstein AE. Analysis and predictors of pulmonary vascular resistance after cardiac transplantation. J Thorac Cardiovasc Surg 1991; 101:432-45.
182. Jugdutt BL, Earnica JW. Intravenous nitroglycerin therapy to limit myocardial infarct size, expansion and complications: effect of timing, dosage and infarct location. Circulation 1988;78:906-19.
183. Pfeffer MA, Lamas G, Vaughan D, Parisi A, Braunwald E. Effect of captopril on progressive ventricular dilation after anterior myocardial infarction. N Engl J Med 1988;319:80-6.
184. Hall S, Cigarroa C, Marcouz L. Regression of hypertrophy and alteration in left ventricular geometry in patients with congestive heart failure treated with beta-adrenergic blockade. Circulation 1994;90(suppl):I543.
185. Scheinin S, Capek P, Radovencevic B, Duncan J, McAllister J, Frazier OH. The effect of prolonged left ventricular support on myocardial histopathology in patients with end-stage cardiomyopathy. ASAIO J 1992;31:M271-4.
186. Jaquet L, Zerbe T, Stein K, Kormos R, Griffith B. Evolution of human cardiac myocyte dimension during prolonged mechanical support. J Thorac Cardiovasc Surg 1991;101:256-9.
187. Levin HR, Oz MC, Chen JM, Packer M, Rose EA, Burkhoff D. Reversal of chronic ventricular dilation in patients with end-stage cardiomyopathy by prolonged mechanical unloading. Circulation 1995;91:2717-20.
188. Mueller J, Wallukat G, Weng Y. Simultaneous reduction in anti-l adrenoreceptor autoantibodies and an improvement in cardiac function during mechanical support: an indication for weaning from assist device? Circulation 1995;92(suppl): 1378-9.
189. Pierce WS, Hershon JJ, Kormos RL, Dembitsky WP, Noon GP. Management of secondary organ dysfunction. Ann Thorac Surg 1993;55:222-6.
190. Borovitz HS, Kormos RL, Griffith BP, Hung T. Clinical utilization of the artificial heart. Crit Rev Biomed Engin 1989;17:179-84.
191. Portner PM, Oyer PE, Pennington DG, Buamgartner WA, Griffith BP, First WR, et al. Implantable electrical left ventricular assist system: bridge to transplantation and the future. Ann Thorac Surg 1989;47:142-50.
192. Joyce LD, Johnson KE, Toninasto CJ, Cabrol C, Griffith B, Copeland JG, et al. Results of the first 100 patients who received Symbion total artificial hearts as a bridge to cardiac transplantation. Circulation 1989;90(suppl III):III 192-201.
193. Didisheim P, Olsen DB, Farrar DJ, Portner PM, Griffith BP, Pennington DG. Infections and thromboembolism with implantable cardiovascular devices. Trans Am Soc Artif Intern Organs 1989;35:54-70.
194. Hravnak M, George E, Kormos RL. Management of chronic left ventricular assist device percutaneous lead insertion sites. J Heart Lung Transplant 1993;12:856-63.
195. Chenoweth DE, Cooper BA, Hugli TE, Stewart RW, Blackstone EH, Kirklin JW. Complement activation during cardiopulmonary bypass. N Engl J Med 1981 ;304: 497-502.
196. Lavelle JP, Duignan JP, Neligan MC. The effects of cardiopulmonary bypass on immune mechanisms of man. Ir J Med Sei 1984;153:431-5.
197. McBride LR, Ruzevich SA, Pennington DG, Kennedy DJ. Infectious complications associated with ventricular assist device support. Trans Am Soc Artif Intern Organs 1987;33:201-2.
198. Griffith BP, Kormos RL, Hardesty RL, Armitage JM, Dummer JS. The artificial heart: infection-related morbidity and its effect on transplantation. Ann Thorac Surg 1988;45:409-14.
199. McBride LR, Swartz MT, Reedy JE, Miller LW, Pennington DG. Device related infections in patients supported with mechanical circulatory support devices for greater than 30 days. ASAIO Trans 1991;37:M258-M259.
200. Argenziano M, Moazami N, Gardocki M, Catanese KA, Rose EA, Oz MC, et al. Infection in patients with heart failure is not a contraindication to LVAD insertion as a bridge to transplantation. J Heart Lung Transplant 1996;15:S87.
201. Catanese KA, Argenziano M, Moazami N, Gardocki MT, Rose EA, Oz MC, et al. Infections in patients with left ventricular assist devices do not preclude successful tranplantation. J Heart Lung Transplant 1996;15:S55.
202. Hill JD, Farrar DJ, Topic N. The Thoratec experience in bridge to cardiac transplantation. Ann Thorac Surg 1993;55:276-82.
203. Danken J, Hogt AH, Feijen J. Biomédical polymers: bacterial adhesion, colonization, and infection. Crit Rev Biotechnol 1986;2:219-301.
204. Icenogle TB, Smith RG, Cleavinger M, Vasu MA, Williams RJ, Setni GK, et al. Thromboembolic complications of the Symbion AVAD system. Artif Organs 1989;13:532-8.
205. Levinson MM, Smith RG, Cork RC. Thromboembolic complications of the Jarvik-7 total artificial heart: case report. Artif Organs 1989;10:236-44.
206. Wagner WR, Johnson PC, Kormos RL, Griffith P. Evaluation of bioprosthetic valve-associated thrombus in ventricular assist device patients. Circulation 1993;88:2023-9.
207. Rose EA, Levin HR, Oz MC, Frazier H, Macmanus Q, Burton NA, et al. Artificial circulatory support with textured interior surfaces: a counter-intuitive approach to minimize thromboembolism. Circulation 1994;90:II87-II91.
208. Moazami N, Argenziano M, Roberts K, Rose EA, Oz MC, Mohr JP, et al. Asymptomatic microembolism in patients with long-term left ventricular assist devices. ASAIO J 1996;42:41.
209. Fith BG, Yancy CW. Survival in congestive heart failure: have we made a difference? Am J Med 1990;88:1N-3N.
210. Miller P, Billich J, LaForge D. Development of a wearable controller for the Novacor LVAS. Ann Biomed Eng 1993;21:18-22.
211. Frazier OH. The development of an implantable, portable, electrically powerd left ventricular assist device. Semin Thorac Cardiovasc Surg !994;6:181-7.
212. Morrone TM, Buck LA, Catanese KA, Goldsmith RM, Cahalin LP, Oz MC, et al. Early progressive mobilization of left ventricular assist device patients is safe and optimizes recovery prior to cardiac transplant. J Heart Lung Transplant 1996;15:423-9.
213. Dew MA, Kormos RL, Roth LH, Armitage JM, Pristac JM, Harris AC, et al. Life quality in the era of bridging to cardiac transplantation: bridge patients in an outpatient setting. ASAIO J 1993:39:145-52.
214. Kendal K, Sharp JW, McCarthy PM. Quality of life for hospitalized implantable LVAD patients. J Heart Lung Transplant 1994:872.
215. Grewal RK, Gelijns AC, Rose EA, Oz MC. Clinical costs associated with LVAD implantation. J Heart Lung Transplant 1995; 14:889.
216. Mehta SM, Aufiero TX, Pae WE, Miller CA, Pierce WS. Mechanical ventricular assistance: an economical and effective means of treating end-stage heart disease. Ann Thorac Surg 1995:60:284-91.
217. Watson JT, Carlsen RR. Request for proposal: development of an implantable integrated electrically powered left heart assist system. RFP NHLBI 80-3, Bethesda, MD, National Institutes of Health: National Heart, Lung, and Blood Institute, January 1980.
218. Whalen RL, Nose Y. Development of a left heart assist blood pump. Bethesda, MD. National Institutes of Health, National Heart, Lung, and Blood Institute. Report NO: NHLBI NO1-HV-7-2934-2, May 1979.
219. Sato N, Snow J, Smith W, Kasich J, Kaneko S, Oison E, et al. Compliance chamber-system integration studies. ASAIO Transactions 1984;30:545-9.
220. Rose EA, Goldstein DJ. Wearable long-term mechanical support for patients with end-stage heart disease: a tenable goal. Ann Thorac Surg 1996;61:399-402.